MedTrace Logo

Male Circumcision for HIV Prevention in Rakai, Uganda

NCT00425984 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2007-08-24

No results posted yet for this study

Summary

Circumcision in HIV unifected men may reduce the likelihood of becoming infected with HIV, reduce sexually transmitted infections (STIs) in men, not engender increases in sexual risk behaviors, and be acceptable to men as a procedure for preventing HIV. The purpose of this study is to evaluate circumcision in HIV uninfected men in terms of safety and ability to prevent HIV infection.

Conditions

  • HIV Infections
  • Herpesvirus 2, Human
  • Syphilis
  • Genital Diseases, Male

Interventions

PROCEDURE

Adult male circumcision

Sponsors & Collaborators

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Ronald H. Gray, MD · Department of Population, Family and Reproductive Health Sciences, Bloomberg School of Public Health, Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-08-31
Completion
2006-12-31

Countries

  • Uganda

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00425984 on ClinicalTrials.gov